相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow et al.
ALZHEIMERS & DEMENTIA (2015)
A Consensus in Korea Regarding a Protocol to Reduce Preanalytical Sources of Variability in the Measurement of the Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
Sun Ah Park et al.
JOURNAL OF CLINICAL NEUROLOGY (2015)
IMPROVED QUANTIFICATION METHODS FOR BRAIN β-AMYLOID BURDEN ON 11C-PIB PET IN PATIENTS WITH ALZHEIMER'S DISEASE
In Kook Chun et al.
Alzheimers & Dementia (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Amyloid-beta 42 adsorption following serial tube transfer
Jamie Toombs et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2012)
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
Clifford R. Jack et al.
ANNALS OF NEUROLOGY (2012)
Diagnostic accuracy of 18F-FDG and 11C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment
S. Zhang et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
Thomas G. Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
N. S. M. Schoonenboom et al.
NEUROLOGY (2012)
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
Michael Scholl et al.
NEUROLOGY (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2011)
Amyloid-β(1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
Cees Mulder et al.
CLINICAL CHEMISTRY (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
E. C. Mormino et al.
BRAIN (2009)
The Effect of Preanalytical Factors on Stability of the Proteome and Selected Metabolites in Cerebrospinal Fluid (CSF)
Therese Rosenling et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Relationships between biomarkers in aging and dementia
W. J. Jagust et al.
NEUROLOGY (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
IIC PiB and structural MRI provide complementary information in imaging of Alzheimers disease and amnestic mild cognitive impairment
Clifford R. Jack et al.
BRAIN (2008)
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Milos D. Ikonomovic et al.
BRAIN (2008)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: Implications for use in clinical practice
NSM Schoonenboom et al.
CLINICAL CHEMISTRY (2005)
CSF tau protein and β-amyloid (1-42) in Alzheimer's disease diagnosis:: discrimination from normal ageing and other dementias in the Greek population
E Kapaki et al.
EUROPEAN JOURNAL OF NEUROLOGY (2003)
What cognitive changes can be expected with normal ageing?
H Christensen
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2001)
分享论文
